Document is current
Any future updates will be listed below
-
Authors
Nagalakshmi, Ugrappa
Rodriguez, Jorge E. https://orcid.org/0000-0002-3177-2586
Nguyen, Thi
Weissman, Rachel F. https://orcid.org/0000-0002-1806-6564
Thornton, Brittney W.
Terrace, Cynthia I. https://orcid.org/0000-0003-1578-9000
Savage, David F.
Dinesh-Kumar, Savithramma P. https://orcid.org/0000-0001-5738-316X
-
Funding
Funding for this research was provided by:
National Science Foundation (IOS-2303522)
National Science Foundation (DGE-2146752)
National Science Foundation (DGE-2146752)
- License Information
-
More Information
Article History
Received: 6 August 2025
Accepted: 26 January 2026
First Online: 20 February 2026
Change Date: 5 March 2026
Change Type: Update
Change Details: This article was originally published under the subscription model but it is now published under an Open Access license.
Competing interests
: A patent application has been filed by The Regents of the University of California, with U.N., J.E.R., B.W.T., R.F.W., C.I.T., D.F.S. and S.P.D.-K. listed as inventors. T.N. declares no competing interests. D.F.S. is a cofounder and member of the scientific advisory board at Scribe Therapeutics.
